Ghada Miremont‐Salamé

2.6k total citations
76 papers, 1.8k citations indexed

About

Ghada Miremont‐Salamé is a scholar working on Toxicology, Pharmacology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ghada Miremont‐Salamé has authored 76 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Toxicology, 22 papers in Pharmacology and 13 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ghada Miremont‐Salamé's work include Pharmacovigilance and Adverse Drug Reactions (33 papers), Drug-Induced Adverse Reactions (14 papers) and Pharmaceutical Practices and Patient Outcomes (11 papers). Ghada Miremont‐Salamé is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (33 papers), Drug-Induced Adverse Reactions (14 papers) and Pharmaceutical Practices and Patient Outcomes (11 papers). Ghada Miremont‐Salamé collaborates with scholars based in France, Belize and Italy. Ghada Miremont‐Salamé's co-authors include Françoise Haramburu, Bernard Bégaud, Nicholas Moore, Annie Fourrier‐Réglat, Hélène Théophile, Alexandre Pariente, Yannick Arimone, Frantz Thiessard, Marie‐Christine Pérault‐Pochat and Mathiéu Molimard and has published in prestigious journals such as Clinical Infectious Diseases, Kidney International and Journal of Clinical Epidemiology.

In The Last Decade

Ghada Miremont‐Salamé

72 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ghada Miremont‐Salamé France 22 801 331 279 261 207 76 1.8k
Françoise Haramburu France 30 1.5k 1.8× 605 1.8× 483 1.7× 417 1.6× 274 1.3× 129 2.7k
Lorna Hazell United Kingdom 11 1.3k 1.7× 427 1.3× 640 2.3× 352 1.3× 142 0.7× 15 2.4k
Preciosa M. Coloma Netherlands 25 673 0.8× 227 0.7× 192 0.7× 138 0.5× 208 1.0× 46 1.9k
Manfred Hauben United States 26 1.4k 1.7× 448 1.4× 265 0.9× 89 0.3× 548 2.6× 77 2.4k
Domenico Motola Italy 25 369 0.5× 424 1.3× 198 0.7× 157 0.6× 59 0.3× 87 1.7k
Bernard Bégaud France 30 1.4k 1.8× 726 2.2× 525 1.9× 392 1.5× 305 1.5× 79 3.0k
Rosa Gini Italy 26 408 0.5× 149 0.5× 294 1.1× 118 0.5× 127 0.6× 123 2.3k
Stephan Lanes United States 29 383 0.5× 333 1.0× 174 0.6× 83 0.3× 89 0.4× 98 4.3k
Hitomi Teramachi Japan 16 294 0.4× 161 0.5× 119 0.4× 187 0.7× 105 0.5× 174 1.2k
Peter Arlett Netherlands 21 461 0.6× 195 0.6× 210 0.8× 96 0.4× 80 0.4× 54 1.8k

Countries citing papers authored by Ghada Miremont‐Salamé

Since Specialization
Citations

This map shows the geographic impact of Ghada Miremont‐Salamé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ghada Miremont‐Salamé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ghada Miremont‐Salamé more than expected).

Fields of papers citing papers by Ghada Miremont‐Salamé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ghada Miremont‐Salamé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ghada Miremont‐Salamé. The network helps show where Ghada Miremont‐Salamé may publish in the future.

Co-authorship network of co-authors of Ghada Miremont‐Salamé

This figure shows the co-authorship network connecting the top 25 collaborators of Ghada Miremont‐Salamé. A scholar is included among the top collaborators of Ghada Miremont‐Salamé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ghada Miremont‐Salamé. Ghada Miremont‐Salamé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Daveluy, Amélie, Valérie Gibaja, Reynald Le Boisselier, et al.. (2024). From regional signal to alert in addictovigilance. Therapies. 80(2). 213–222. 2 indexed citations
2.
Miremont‐Salamé, Ghada, et al.. (2024). ASOS, a national monitoring study to assess narcotic prescriptions and indications in France since 2001. Therapies. 80(2). 187–195. 4 indexed citations
3.
Bennetau‐Pelissero, Catherine, et al.. (2022). Herb-drug interaction resources: The PHYDGI database. Phytomedicine Plus. 2(3). 100324–100324. 3 indexed citations
4.
5.
Martin, M., Franck Rouby, Marion Sassier, et al.. (2020). Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer. Journal for ImmunoTherapy of Cancer. 8(2). e001622–e001622. 84 indexed citations
6.
Gouverneur, Amandine, Pauline Bosco‐Lévy, Aurore Gouraud, et al.. (2019). Adverse events reported for Mirena levonorgestrel‐releasing intrauterine device in France and impact of media coverage. British Journal of Clinical Pharmacology. 85(9). 2126–2133. 14 indexed citations
7.
Miremont‐Salamé, Ghada, et al.. (2018). Du médicament psychoactif à l’addictovigilance dans le Code de la santé publique en France (1990–2017). Therapies. 74(3). 375–382. 18 indexed citations
8.
Daveluy, Amélie, et al.. (2018). Addictovigilance dans les départements d’Outre-Mer. Therapies. 73(6). 565–565.
9.
Iaru, Irina, Ghada Miremont‐Salamé, Cristina Mogoșan, et al.. (2015). Preventability of adverse effects of analgesics: analysis of spontaneous reports. European Journal of Clinical Pharmacology. 71(5). 625–629. 9 indexed citations
10.
11.
Pariente, Alexandre, Paul Avillach, Francesco Salvo, et al.. (2012). Effect of Competition Bias in Safety Signal Generation. Drug Safety. 35(10). 855–864. 59 indexed citations
12.
Daveluy, Amélie, Ghada Miremont‐Salamé, Catherine Lecomte, et al.. (2012). Identification of abuse and dependence cases through a hospital database. Pharmacoepidemiology and Drug Safety. 21(12). 1344–1349. 21 indexed citations
13.
Théophile, Hélène, Ghada Miremont‐Salamé, Philip Robinson, et al.. (2011). Relevance of a “Dear Doctor letter” to alert healthcare providers to new recommendations for vitamin D administration. European Journal of Clinical Pharmacology. 67(7). 681–686. 16 indexed citations
14.
Lawson‐Ayayi, S., Renaud de la Faille, Fabrice Bonnet, et al.. (2011). Increased risk of abnormal proximal renal tubular function with HIV infection and antiretroviral therapy. Kidney International. 80(3). 302–309. 84 indexed citations
15.
Pariente, Alexandre, Amélie Daveluy, Anne Bénard‐Laribière, et al.. (2009). Effect of Date of Drug Marketing on Disproportionality Measures in Pharmacovigilance. Drug Safety. 32(5). 441–447. 18 indexed citations
16.
Doussau, A., Frantz Thiessard, Ghada Miremont‐Salamé, C. Conri, & Françoise Haramburu. (2006). Effets indésirables psychiatriques des fluoroquinolones : cas notifiés à la pharmacovigilance française. La Revue de Médecine Interne. 27(6). 448–452. 12 indexed citations
17.
Arimone, Yannick, Bernard Bégaud, Ghada Miremont‐Salamé, et al.. (2005). Agreement of expert judgment in causality assessment of adverse drug reactions. European Journal of Clinical Pharmacology. 61(3). 169–173. 77 indexed citations
18.
Bénard‐Laribière, Anne, et al.. (2005). Des terpènes dans les cosmétiques : à propos de deux cas de convulsions. Therapies. 60(6). 607–609. 2 indexed citations
19.
Lagnaoui, Rajaa, Nicholas Moore, Yola Moride, Ghada Miremont‐Salamé, & Bernard Bégaud. (2003). Benzodiazepine utilization patterns in Alzheimer's disease patients. Pharmacoepidemiology and Drug Safety. 12(6). 511–515. 13 indexed citations
20.
Bégaud, Bernard, et al.. (2003). Differences between clinical trials and postmarketing use. British Journal of Clinical Pharmacology. 57(1). 86–92. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Françoise Haramburu Breakdown of academic impact, for papers by Lorna Hazell Breakdown of academic impact, for papers by Preciosa M. Coloma Breakdown of academic impact, for papers by Manfred Hauben Breakdown of academic impact, for papers by Domenico Motola Breakdown of academic impact, for papers by Bernard Bégaud Breakdown of academic impact, for papers by Rosa Gini Breakdown of academic impact, for papers by Stephan Lanes Breakdown of academic impact, for papers by Hitomi Teramachi Breakdown of academic impact, for papers by Peter Arlett
Rankless by CCL
2026